357 related articles for article (PubMed ID: 24650132)
1. Drug delivery across the blood-brain barrier using focused ultrasound.
Burgess A; Hynynen K
Expert Opin Drug Deliv; 2014 May; 11(5):711-21. PubMed ID: 24650132
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive and targeted drug delivery to the brain using focused ultrasound.
Burgess A; Hynynen K
ACS Chem Neurosci; 2013 Apr; 4(4):519-26. PubMed ID: 23379618
[TBL] [Abstract][Full Text] [Related]
3. Focused ultrasound-mediated drug delivery through the blood-brain barrier.
Burgess A; Shah K; Hough O; Hynynen K
Expert Rev Neurother; 2015 May; 15(5):477-91. PubMed ID: 25936845
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Zhao YZ; Lu CT; Li XK; Cai J
Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
[TBL] [Abstract][Full Text] [Related]
5. Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound.
Anastasiadis P; Gandhi D; Guo Y; Ahmed AK; Bentzen SM; Arvanitis C; Woodworth GF
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34504017
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.
McMahon D; Poon C; Hynynen K
Expert Opin Drug Deliv; 2019 Feb; 16(2):129-142. PubMed ID: 30628455
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of focused ultrasound induced blood-brain barrier opening, an integrative review of animal and human studies.
Meng Y; Pople CB; Lea-Banks H; Abrahao A; Davidson B; Suppiah S; Vecchio LM; Samuel N; Mahmud F; Hynynen K; Hamani C; Lipsman N
J Control Release; 2019 Sep; 309():25-36. PubMed ID: 31326464
[TBL] [Abstract][Full Text] [Related]
9. Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening.
Ji R; Karakatsani ME; Burgess M; Smith M; Murillo MF; Konofagou EE
J Control Release; 2021 Sep; 337():458-471. PubMed ID: 34324895
[TBL] [Abstract][Full Text] [Related]
10. Focused Ultrasound-Induced Blood-Brain Barrier Opening: Association with Mechanical Index and Cavitation Index Analyzed by Dynamic Contrast-Enhanced Magnetic-Resonance Imaging.
Chu PC; Chai WY; Tsai CH; Kang ST; Yeh CK; Liu HL
Sci Rep; 2016 Sep; 6():33264. PubMed ID: 27630037
[TBL] [Abstract][Full Text] [Related]
11. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
[TBL] [Abstract][Full Text] [Related]
12. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
13. Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier.
Todd N; Angolano C; Ferran C; Devor A; Borsook D; McDannold N
J Control Release; 2020 Aug; 324():450-459. PubMed ID: 32470359
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-mediated blood-brain barrier opening: An effective drug delivery system for theranostics of brain diseases.
Wang J; Li Z; Pan M; Fiaz M; Hao Y; Yan Y; Sun L; Yan F
Adv Drug Deliv Rev; 2022 Nov; 190():114539. PubMed ID: 36116720
[TBL] [Abstract][Full Text] [Related]
15. Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease.
Dubey S; Heinen S; Krantic S; McLaurin J; Branch DR; Hynynen K; Aubert I
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32691-32700. PubMed ID: 33288687
[TBL] [Abstract][Full Text] [Related]
16. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier opening in a large animal model using closed-loop microbubble cavitation-based feedback control of focused ultrasound sonication.
Chien CY; Xu L; Pacia CP; Yue Y; Chen H
Sci Rep; 2022 Sep; 12(1):16147. PubMed ID: 36167747
[TBL] [Abstract][Full Text] [Related]
18. Natural aging and Alzheimer's disease pathology increase susceptibility to focused ultrasound-induced blood-brain barrier opening.
Noel RL; Batts AJ; Ji R; Pouliopoulos AN; Bae S; Kline-Schoder AR; Konofagou EE
Sci Rep; 2023 Apr; 13(1):6757. PubMed ID: 37185578
[TBL] [Abstract][Full Text] [Related]
19. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery.
Nainwal N
Curr Drug Targets; 2017; 18(11):1225-1232. PubMed ID: 28017126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
